Moderna Advances Novel Cancer Therapy to Treat Challenging Blood Disorders

Cambridge, Wednesday, 4 November 2026.
Moderna revealed early trial success treating heavily pretreated multiple myeloma patients using a new multi-target therapy, with key data scheduled for an oral presentation this December.